MedTrace Logo

Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers

NCT00780182 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2010-02-02

No results posted yet for this study

Summary

The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.

Conditions

  • Healthy

Interventions

DRUG

CMX001

CMX001 tablet fasted, CMX001 tablet fed, CMX001 solution fasted

Sponsors & Collaborators

Principal Investigators

  • Evin H Sides, III, MD · AAIPharma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2008-12-31
Completion
2009-01-31

Countries

  • United States

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00780182 on ClinicalTrials.gov